Lupin Limited has informed the Exchange regarding a press release dated March 21, 2023, titled "Lupin Receives Approval from US FDA for Brexpiprazole Tablets.".
Press Release Mar 21 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Mar 20 2023
- Press Release Mar 17 2023
- Press Release Mar 13 2023
- Press Release Mar 10 2023
- Press Release Mar 01 2023
Later from Lupin
- Press Release Mar 23 2023
- Press Release Mar 25 2023
- Press Release Mar 27 2023
- Press Release Mar 31 2023
- Press Release Apr 12 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin